187 related articles for article (PubMed ID: 27605722)
1. Serum C-reactive protein levels in pre-dialysis chronic kidney disease patientsin southern Nigeria.
Adejumo OA; Okaka EI; Okwuonu CG; Iyawe IO; Odujoko OO
Ghana Med J; 2016 Mar; 50(1):31-8. PubMed ID: 27605722
[TBL] [Abstract][Full Text] [Related]
2. Lipid profile in pre-dialysis chronic kidney disease patients in southern Nigeria.
Adejumo OA; Okaka EI; Ojogwu LI
Ghana Med J; 2016 Mar; 50(1):44-9. PubMed ID: 27605724
[TBL] [Abstract][Full Text] [Related]
3. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.
Sonmez A; Yilmaz MI; Saglam M; Unal HU; Gok M; Cetinkaya H; Karaman M; Haymana C; Eyileten T; Oguz Y; Vural A; Rizzo M; Toth PP
Lipids Health Dis; 2015 Apr; 14():29. PubMed ID: 25885289
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.
Lamprea-Montealegre JA; Staplin N; Herrington WG; Haynes R; Emberson J; Baigent C; de Boer IH;
Clin J Am Soc Nephrol; 2020 Jan; 15(1):47-60. PubMed ID: 31831577
[TBL] [Abstract][Full Text] [Related]
5. Combination of low body mass index and serum albumin level is associated with chronic kidney disease progression: the chronic kidney disease-research of outcomes in treatment and epidemiology (CKD-ROUTE) study.
Kikuchi H; Kanda E; Mandai S; Akazawa M; Iimori S; Oi K; Naito S; Noda Y; Toda T; Tamura T; Sasaki S; Sohara E; Okado T; Rai T; Uchida S
Clin Exp Nephrol; 2017 Feb; 21(1):55-62. PubMed ID: 26920126
[TBL] [Abstract][Full Text] [Related]
6. Combinative predictive effect of left ventricular mass index, ratio of HDL and CRP for progression of chronic kidney disease in non-dialysis patient.
Tang L; Li S; Guo X; Lai J; Liu P; Fang J; Liu X
Int Urol Nephrol; 2024 Jan; 56(1):205-215. PubMed ID: 37204678
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Syndrome-Associated Risk Factors and High-Sensitivity C-Reactive Protein Independently Predict Arterial stiffness in 9903 Subjects With and Without Chronic Kidney Disease.
Tsai SS; Lin YS; Lin CP; Hwang JS; Wu LS; Chu PH
Medicine (Baltimore); 2015 Sep; 94(36):e1419. PubMed ID: 26356694
[TBL] [Abstract][Full Text] [Related]
8. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study.
Lee Y; Park S; Lee S; Kim Y; Kang MW; Cho S; Park S; Han K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
PLoS One; 2020; 15(4):e0231328. PubMed ID: 32271842
[TBL] [Abstract][Full Text] [Related]
9. Chronic Kidney Disease and Lipid Disorders.
Zubovic SV; Kristic S; Prevljak S; Pasic IS
Med Arch; 2016 Jun; 70(3):191-2. PubMed ID: 27594744
[TBL] [Abstract][Full Text] [Related]
10. Hypomagnesemia and atherogenic dyslipidemia in chronic kidney disease: surrogate markers for increased cardiovascular risk.
Dey R; Rajappa M; Parameswaran S; Revathy G
Clin Exp Nephrol; 2015 Dec; 19(6):1054-61. PubMed ID: 25697595
[TBL] [Abstract][Full Text] [Related]
11. Association of blood lipid profile with incident chronic kidney disease: A Mendelian randomization study.
Zhang YB; Sheng LT; Wei W; Guo H; Yang H; Min X; Guo K; Yang K; Zhang X; He M; Wu T; Pan A
Atherosclerosis; 2020 May; 300():19-25. PubMed ID: 32276134
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C, CRP, log TG/HDLc and metabolic syndrome are associated with microalbuminuria in hypertension.
Moura Rdo S; Vasconcelos DF; Freitas E; Moura FJ; Rosa TT; Veiga JP
Arq Bras Cardiol; 2014 Jan; 102(1):54-9. PubMed ID: 24162470
[TBL] [Abstract][Full Text] [Related]
13. Study on Blood Pressure, e-GFR, Serum Albumin, C-reactive Protein in Normal Subjects and Patients with CKD.
Huq MM; Nessa A; Rahman F; Sharmin T; Yeasmin F; Taufiq-Ul-Alam M; Diluara K
Mymensingh Med J; 2023 Oct; 32(4):922-926. PubMed ID: 37777881
[TBL] [Abstract][Full Text] [Related]
14. Serum Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease in Community Dwellers with Chronic Kidney Disease: the Hisayama Study.
Usui T; Nagata M; Hata J; Mukai N; Hirakawa Y; Yoshida D; Kishimoto H; Kitazono T; Kiyohara Y; Ninomiya T
J Atheroscler Thromb; 2017 Jul; 24(7):706-715. PubMed ID: 27840387
[TBL] [Abstract][Full Text] [Related]
15. Correlates of leptin in children with chronic kidney disease.
Nehus E; Furth S; Warady B; Mitsnefes M
J Pediatr; 2014 Oct; 165(4):825-9. PubMed ID: 25066063
[TBL] [Abstract][Full Text] [Related]
16. Relationship between liver function tests & cardiovascular risk factors in stage 3-5 pre-dialysis chronic kidney disease.
Selen T; Akoglu H; Agbaht K
Indian J Med Res; 2022 Mar; 155(3&4):397-402. PubMed ID: 35975350
[TBL] [Abstract][Full Text] [Related]
17. Does chronic kidney disease modify the association between body mass index and cardiovascular disease risk factors.
Bansal N; Vittinghoff E; Plantinga L; Hsu CY
J Nephrol; 2012; 25(3):317-24. PubMed ID: 21725923
[TBL] [Abstract][Full Text] [Related]
18. There is a U shaped association between non high density lipoprotein cholesterol with overall and cardiovascular mortality in chronic kidney disease stage 3-5.
Chiu H; Wu PY; Huang JC; Tu HP; Lin MY; Chen SC; Chang JM
Sci Rep; 2020 Jul; 10(1):12749. PubMed ID: 32728174
[TBL] [Abstract][Full Text] [Related]
19. Dietary, anthropometric, and biochemical determinants of uric acid in free-living adults.
de Oliveira EP; Moreto F; Silveira LV; Burini RC
Nutr J; 2013 Jan; 12():11. PubMed ID: 23311699
[TBL] [Abstract][Full Text] [Related]
20. Association of elevated blood serum high-sensitivity C-reactive protein levels and body composition with chronic kidney disease: A population-based study in Taiwan.
Tsai YW; Chan YL; Chen YC; Cheng YH; Chang SS
Medicine (Baltimore); 2018 Sep; 97(36):e11896. PubMed ID: 30200074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
